Finance

Beta
Lists
300261:SHE
ABA Chemicals Corp
CN¥4.98
+1.43%
(+0.070) 1D
Jun 5, 3:04:34 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300261...
Open
CN¥4.91
High
CN¥5.01
Low
CN¥4.85
Mkt. cap
4.73B
Avg. vol.
11.50M
Volume
9.94M
52-wk high
CN¥9.10
52-wk low
CN¥4.85
EPS
-CN¥0.22
Shares outstanding
963.31M
No. of employees
1K
Open
CN¥4.91
High
CN¥5.01
Low
CN¥4.85
Mkt. cap
4.73B
Avg. vol.
11.50M
Volume
9.94M
52-wk high
CN¥9.10
52-wk low
CN¥4.85
EPS
-CN¥0.22
Shares outstanding
963.31M
No. of employees
1K
News stories
From sources across the web
Profile
ABA Chemicals, also known as Abachem, is a Chinese chemical manufacturing company headquartered in Taicang. The company was founded in 2006 as Suzhou ABA Chemicals, and is traded on the Shenzhen Stock Exchange as 300261. The company provides contract development and manufacturing services to the pharmaceutical, biotechnological, and agrochemical industries. It offers various services for the production of fine chemicals; intermediates; and active pharmaceutical ingredients. The company also provides unnatural amino acids, pyrazoles, triazoles, and azaindoles, as well as producing an intermediate of API Levetiracetam for the treatment of epilepsy. The company is also involved in pesticide manufacturing intermediates, and acquired the Chinese firm Shanghai Puyi Chemical to consolidate its position in this market. It also acquired Amino Chemicals, a pharmaceutical API intermediate manufacturer and member of the Dipharma Group, in 2017; Amino is based on Malta and was established in 1992. ABA and Dipharma began a working partnership in the 1980s, which provided Dipharma access to the Chinese pharmaceutical market. Wikipedia
About ABA Chemicals Corp
CEO-
Employees1.2K
FoundedJan 13, 2006
Headquarters-
SectorSpeciality chemicals
Websiteabachem.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
346.01M
334.69M
310.82M
303.59M
Cost of goods sold
291.94M
248.45M
300.89M
286.91M
Cost of revenue
291.94M
248.45M
300.89M
286.91M
Research and development expenses
27.62M
29.18M
28.68M
20.19M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
36.42M
48.48M
37.47M
41.02M
Operating expense
71.36M
81.42M
103.89M
61.97M
Total operating expenses
363.31M
329.87M
404.78M
348.88M
Operating income
-17.30M
4.82M
-93.96M
-45.29M
Other non operating income
-6.17M
15.52M
-16.13M
-19.79M
EBT including unusual items
364.76K
-2.79M
-177.93M
-73.15M
EBT excluding unusual items
-14.88M
-1.61M
-124.19M
-65.07M
Income tax expense
-1.79M
-3.44M
-6.13M
-14.24M
Effective tax rate
-490.84%
123.57%
3.45%
19.47%
Other operating expenses
2.92M
2.79M
-849.91K
758.64K
Net income
4.09M
1.75M
-152.59M
-57.58M
Net profit margin
1.18%
0.52%
-49.09%
-18.97%
Earnings per share
-
-
-
-
Interest and investment income
426.83K
5.04M
-
-
Interest expense
-9.10M
-9.72M
-15.90M
-
Net interest expenses
-8.68M
-4.68M
-15.90M
-
Depreciation and amortization charges
-
-
-
-
EBITDA
17.50M
38.18M
-59.20M
-10.52M
Gain or loss from assets sale
-110.13K
110.13K
-161.52K
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer